Skip to main content

All News

ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.

1 - 10 of 250 Results

ORNL researcher Jesse Labbe is working with plants in a greenhouse. He is framed on all sides with bright green leaves

Jesse Labbé aims to leverage biology, computation and engineering to address societal challenges related to energy, national security and health, while enhancing U.S. competitiveness. Labbé emphasizes the importance of translating groundbreaking research into practical applications that have real-world impact.

Erica Prates is presenting to a group of attendees at Vandy workshop in a table conference room, standing next to a screen glowing in white

Scientists at the Department of Energy’s Oak Ridge National Laboratory recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.

Research scientist Daniel Jacobson is standing with his arms crossed with a dark black backdrop

Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology. 

Different groups of proteins shown in different colors combine and attach to a broken strand of DNA.

Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.

the foreground shows new macromolecules that could be made using a process invented by Oak Ridge National Laboratory chemists to upcycle the polymers from discarded plastics.

By editing the polymers of discarded plastics, ORNL chemists have found a way to generate new macromolecules with more valuable properties than those of the starting material.

Procter & Gamble scientists used ORNL’s Summit supercomputer to create a digital model of the corneal epithelium, the primary outer layer of cells covering the human eye, and test that model against a series of cleaning compounds in search of a gentler, more environmentally sustainable formula.

P&G is using simulations on the ORNL Summit supercomputer to study how surfactants in cleaners cause eye irritation. By modeling the corneal epithelium, P&G aims to develop safer, concentrated cleaning products that meet performance and safety standards while supporting sustainability goals.

Emrullah Aydin, an ORNL research is posing for a headshot in a black suit with black tie
Emrullah Aydin, an R&D staff associate in the Vehicle Power Electronics Research group at the Department of Energy’s Oak Ridge National Laboratory, has been elevated to senior member status in the Institute of Electrical and Electronics Engineers.
Vivek Sujan is posing for a photo in a suit jacket with brown stairs and grey and brown background

Vivek Sujan, a distinguished R&D scientist in the Applied Research for Mobility Systems group at ORNL, has been named a 2024 National Association of Inventors Fellow for his numerous transportation-related patents. 

ORNL chemist Benjamin Manard is posing for a photo with a light blue and navy background

Benjamin Manard, a nuclear analytical chemist at ORNL, has been named the 2025 winner of the Emerging Leader in Atomic Spectroscopy Award from Spectroscopy magazine. 

A male researcher is standing next to a poster board displayed on an easel to the right. The researcher is dressed in professional attire, and the poster board is positioned beside him, showing research or visual information.

Ryan Culler is the program manager at Oak Ridge National Laboratory, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.